Luye Innomind Pharma

Luye Innomind Pharma is a specialized subsidiary of the Luye Pharma Group, focusing on the research, development, and manufacturing of innovative formulations and complex delivery systems. The company leverages advanced technology platforms such as microspheres, liposomes, and lipid nanoparticles to improve the efficacy and safety of treatments in central nervous system (CNS) disorders and oncology. In addition to its internal pipeline, Luye Innomind operates as a high-end CDMO, providing integrated services from early-stage development to commercial-scale production. Its state-of-the-art facilities are designed to meet global GMP standards, supporting the group's international expansion strategy in markets including China, the U.S., and Europe.